My Week in Westminster - 3rd March 2017

Introduced a 10 Minute Rule Bill to the House of Commons – my Bill aims to protect trans people from unintended public disclosure of their former names by the Registrar of Companies. If you would like to read my speech, please see here: https://hansard.parliament.uk/Commons/2017-03-01/debates/FD0E3A16-8854-407E-AA48-DBA07F86AC57/CompaniesDocumentation(TransgenderPersons)#contribution-9F7EC05F-DFB0-4D88-BE88-F08E707A9C3E

 

Voted in favour of the Backbench Motion on the Dubs Amendment – following my contribution to the debate last week, I was pleased that this motion was passed by 254 votes to 1. I shall continue to support calls for the Government to transfer more refugee children to the UK under the Dubs Scheme.

 

Hosted the Association of East Midlands Colleges event in Parliament – this reception, attended by Principals, Chief Executives, Governors, students, senior figures from major businesses and representatives from local government and LEPs, provided colleges across the East Midlands with an opportunity to showcase and celebrate the excellent work of the further education and skills sector. More information about the Association can be found here: https://www.aoc.co.uk/about-us/aoc-regions/aoc-east-midlands

 

Attended the launch of Ecodesign Ready Stoves – I was invited to attend this event by a local ceramic supplies company to hear more about the Stove Industry Appliance (SIA) and their commitment to reducing air pollution. More information about the SIA can be found here: http://www.stoveindustryalliance.com/

 

Raised a local resident’s concern about the availability of palbociclib with the Health Secretary – the National Institute for Health and Care Excellence (NICE) recently held a consultation on its draft guidance not to recommend palbociclib for people who have not had any treatments for their locally advanced or metastatic breast cancer. I wrote to the Minister to raise a resident’s concerns about this. If you would like more information about the NICE’s decision, please see here: https://www.nice.org.uk/news/article/breast-cancer-drug-costs-too-high-in-relation-to-benefits-for-routine-nhs-funding